Money NewsMoney News

Leslie Chong, Imugene CEO

View descriptionShare

Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 3 playlist(s)

Money News

Money News — the most respected business program on radio. If you crave the latest insights into su 
Social links
Follow podcast
Recent clips
Browse 12,855 clip(s)